Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF STOCK GRANT VESTING PERIODS (Details)

v3.22.1
SCHEDULE OF STOCK GRANT VESTING PERIODS (Details)
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Stock options outstanding, Number of shares, beginning | shares 641,337
Stock options outstanding, Weighted Average Remaining Life (Years) 7 years 6 months 18 days
Stock options outstanding, Weighted Average Exercise Price, Beginning | $ / shares $ 6.27
Issued, Number of shares | shares 44,410
Issued, Weighted Average Remaining Life (Years) 9 years 9 months 18 days
Issued, Weighted Average Exercise Price | $ / shares $ 10.48
Expired, Number of shares | shares
Expired, Weighted Average Remaining Life (Years)
Expired, Weighted Average Exercise Price | $ / shares
Exercised, Number of shares | shares (4,555)
Exercised, Weighted Average Exercise Price | $ / shares $ 6.00
Stock options outstanding, Number of shares, ending | shares 681,192
Stock options outstanding, Weighted Average Remaining Life (Years) 7 years 9 months
Stock options outstanding, Weighted Average Exercise Price, Ending | $ / shares $ 6.63
Stock options exercisable | shares 579,169
Stock options exercisable, Weighted Average Remaining Life (Years) 7 years 4 months 28 days
Stock options exercisable, Weighted Average Exercise Price | $ / shares $ 6.44